Cite
Metformin reduces decline in the estimated glomerular filtration rate during progression of autosomal dominant polycystic kidney disease: a systematic review and meta-analysis.
MLA
Yao, F., et al. “Metformin Reduces Decline in the Estimated Glomerular Filtration Rate during Progression of Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis.” European Review for Medical & Pharmacological Sciences, vol. 27, no. 24, Dec. 2023, pp. 11904–12. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=174567269&authtype=sso&custid=ns315887.
APA
Yao, F., Huang, S.-Q., Cheng, X.-S., Li, K., & Jiang, X.-L. (2023). Metformin reduces decline in the estimated glomerular filtration rate during progression of autosomal dominant polycystic kidney disease: a systematic review and meta-analysis. European Review for Medical & Pharmacological Sciences, 27(24), 11904–11912.
Chicago
Yao, F., S.-Q. Huang, X.-S. Cheng, K. Li, and X.-L. Jiang. 2023. “Metformin Reduces Decline in the Estimated Glomerular Filtration Rate during Progression of Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis.” European Review for Medical & Pharmacological Sciences 27 (24): 11904–12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=174567269&authtype=sso&custid=ns315887.